List of works - Pasquale Pisapia

A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer

scientific article published on 27 January 2019

ALK and ROS1 testing on lung cancer cytologic samples: Perspectives

scientific article

BRAF Mutations in Lung Cancer

scientific article published on 06 March 2019

BRAF: A Two-Faced Janus

scientific article published on 27 November 2020

Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting

scientific article published in October 2017

Ciliated foregut cyst of the pancreas: a benign lesion with elevated CEA levels

scientific article published on 28 March 2014

Circulating Tumour Cells in Predictive Molecular Pathology: Focus on Drug-Sensitive Assays and 3D Culture

scientific article published on 13 February 2019

Comparison between two different next generation sequencing platforms for clinical relevant gene mutation test in solid tumours

scientific article published on 14 February 2020

Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.

scientific article published on 5 May 2017

Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens

scientific article published on 25 April 2019

Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx

scientific article published on 22 April 2020

Cytopathologists can reliably perform ultrasound-guided thyroid fine needle aspiration: a 1-year audit on 3715 consecutive cases.

scientific article published on 21 March 2015

Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.

scientific article published on 7 February 2017

Differential clinical outcome according to KRAS, NRAS and BRAF genotype detected by massive parallel sequencing of metastatic colorectal cancer patients treated with first line FIr-B/FOx adding bevacizumab to triplet chemotherapy

scientific article published on 01 June 2017

Digital Pathology and PD-L1 Testing in Non Small Cell Lung Cancer: A Workshop Record

scientific article published on 05 July 2020

EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay.

scientific article published on 19 August 2016

EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: a validation study

scientific article

Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy

scientific article published on 10 December 2019

Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries

scientific article published on 27 October 2020

Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel

scientific article published on 11 March 2020

How to prepare cytological samples for molecular testing

scientific article

Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study

scientific article published on 02 September 2020

Invited review-next-generation sequencing: a modern tool in cytopathology

scientific article published on 15 March 2019

Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study

scientific article published on 20 May 2019

Juggling the COVID-19 pandemic: a cytopathologist point of view

scientific article published on 03 November 2020

KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test.

scientific article published on 24 February 2017

KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy.

scientific article published on 29 May 2018

Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases

scientific article published on 21 January 2016

Liquid Biopsy and Lung Cancer

scientific article published on 19 December 2018

Liquid biopsy for <i>BRAF</i> mutations testing in non-small cell lung cancer: a retrospective study

scientific article published on 04 December 2020

Mismatch repair proteins and microsatellite instability in solid pseudopapillary neoplasm of the pancreas

scientific article published on 22 August 2019

Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study.

scientific article

Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?

scientific article published on 19 March 2019

Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients

scientific article

Osimertinib

scientific article published on 01 January 2018

PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation

scientific article published on 25 April 2020

PD-L1 expression on routine samples of non-small cell lung cancer: results and critical issues from a 1-year experience of a centralised laboratory

scientific article published on 07 March 2019

Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker.

scientific article published on 24 April 2019

Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples

scientific article published on 02 October 2018

Predictive biomarkers for molecular pathology in lung cancer

scientific article published on 03 March 2020

Predictive molecular pathology in the time of COVID-19

scientific article published on 19 May 2020

Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe

scientific article published on 31 July 2020

Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer.

scientific article published on 27 January 2017

RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer

scientific article published on 04 January 2021

Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis

scientific article published on 06 January 2020

Role of Cytomorphology in the Era of Liquid Biopsy

scientific article published on 03 April 2019

Targeting emerging molecular alterations in the treatment of non-small cell lung cancer: current challenges and the way forward

scientific article published on 26 February 2020

The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer

scientific article published on 08 June 2019

The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology

scientific article published on 04 August 2020

The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal

scientific article published on 21 February 2020

There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression.

scientific article published on 31 March 2017

Tumor mutational burden on cytological samples: A pilot study

scientific article published on 30 December 2020

Understanding EGFR heterogeneity in lung cancer

scientific article published on 01 October 2020

List of works by Pasquale Pisapia

A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer

ALK and ROS1 testing on lung cancer cytologic samples: Perspectives

BRAF Mutations in Lung Cancer

BRAF: A Two-Faced Janus

Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting

Ciliated foregut cyst of the pancreas: a benign lesion with elevated CEA levels

Circulating Tumour Cells in Predictive Molecular Pathology: Focus on Drug-Sensitive Assays and 3D Culture

Comparison between two different next generation sequencing platforms for clinical relevant gene mutation test in solid tumours

Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.

Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens

Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx

Cytopathologists can reliably perform ultrasound-guided thyroid fine needle aspiration: a 1-year audit on 3715 consecutive cases.

Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.

Differential clinical outcome according to KRAS, NRAS and BRAF genotype detected by massive parallel sequencing of metastatic colorectal cancer patients treated with first line FIr-B/FOx adding bevacizumab to triplet chemotherapy

Digital Pathology and PD-L1 Testing in Non Small Cell Lung Cancer: A Workshop Record

EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay.

EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: a validation study

Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy

Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries

Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel

How to prepare cytological samples for molecular testing

Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study

Invited review-next-generation sequencing: a modern tool in cytopathology

Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study

Juggling the COVID-19 pandemic: a cytopathologist point of view

KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test.

KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy.

Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases

Liquid Biopsy and Lung Cancer

Liquid biopsy for <i>BRAF</i> mutations testing in non-small cell lung cancer: a retrospective study

Mismatch repair proteins and microsatellite instability in solid pseudopapillary neoplasm of the pancreas

Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study.

Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?

Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients

Osimertinib

PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation

PD-L1 expression on routine samples of non-small cell lung cancer: results and critical issues from a 1-year experience of a centralised laboratory

Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker.

Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples

Predictive biomarkers for molecular pathology in lung cancer

Predictive molecular pathology in the time of COVID-19

Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe

Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer.

RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer

Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis

Role of Cytomorphology in the Era of Liquid Biopsy

Targeting emerging molecular alterations in the treatment of non-small cell lung cancer: current challenges and the way forward

The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer

The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology

The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal

There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression.

Tumor mutational burden on cytological samples: A pilot study

Understanding EGFR heterogeneity in lung cancer